First Time Loading...

Know Labs Inc
OTC:KNWN

Watchlist Manager
Know Labs Inc Logo
Know Labs Inc
OTC:KNWN
Watchlist
Price: 1.52 USD Market Closed
Updated: Mar 29, 2024

Intrinsic Value

KNWN price has not been updated for more than 2 months. This may indicate that the stock has been delisted.
KNWN's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. [ Read More ]

The intrinsic value of one KNWN stock under the Base Case scenario is 0.24 USD. Compared to the current market price of 1.52 USD, Know Labs Inc is Overvalued by 84%.

Key Points:
KNWN Intrinsic Value
Base Case
0.24 USD
Overvaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Know Labs Inc

Backtest KNWN Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling KNWN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Know Labs Inc

Balance Sheet Decomposition is not available for
Know Labs Inc
Efficiency

Earnings Waterfall
Know Labs Inc

Revenue
4.4m USD
Operating Expenses
-16.9m USD
Operating Income
-12.6m USD
Other Expenses
-7.5m USD
Net Income
-20.1m USD

Free Cash Flow Analysis
Know Labs Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

KNWN Profitability Score
Profitability Due Diligence

Know Labs Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

39/100
Profitability
Score

Know Labs Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

KNWN Solvency Score
Solvency Due Diligence

Know Labs Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
53/100
Solvency
Score

Know Labs Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KNWN Price Targets Summary
Know Labs Inc

There are no price targets for KNWN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

KNWN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

KNWN Price
Know Labs Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-54%
5Y 5Y
+21%
10Y 10Y
-89%
Annual Price Range
1.52
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 37.76%
Standard Deviation of Annual Returns 52.11%
Max Drawdown -70%
Shares Statistics
Market Capitalization 66.5m USD
Shares Outstanding 43 737 772
Percentage of Shares Shorted
N/A

KNWN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Know Labs Inc Logo
Know Labs Inc

Country

United States of America

Industry

Electrical Equipment

Market Cap

66.5m USD

Dividend Yield

0%

Description

Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Seattle, Washington and currently employs 12 full-time employees. The company went IPO on 2006-04-12. The firm offers technology that uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The firm offers a technology called Bio-RFID, which identifies and provides the user with real-time information on their blood glucose levels. Bio-RFID can be integrated into a variety of wearable, mobile or bench-top form factors. Bio-RFID uses radio waves to identify and measure what is going on inside the body. The firm offers UBAND, which is a wearable non-invasive glucose monitor that measures blood glucose levels without fingerpricks or needles. The company helps people with diabetes and pre-diabetes manage their conditions. UBAND’s Bio-RFID sensor detects molecular signatures in other substances such as oxygen, alcohol, and metabolized drugs. Its user can subscribe to multiple monthly services for medical reasons and others lifestyle.

Contact

WASHINGTON
Seattle
500 Union St Ste 810
+12069031351.0
https://www.knowlabs.co/

IPO

2006-04-12

Employees

12

Officers

Founder, Chairman & Treasurer
Mr. Ronald P. Erickson J.D.
CEO & Director
Mr. Phillip A. Bosua
CFO & Sr. VP of Intellectual Property
Mr. Peter Joseph Conley
Chief Marketing Officer
Mr. Leonardo Troutwein
Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
Dr. James H. Anderson Jr., M.D.
Chief Product Officer
Mr. Steven T. Kent
Show More
Sr. VP of Software Engineering
Mr. Masanori Takee
Show Less

See Also

Discover More
What is the Intrinsic Value of one KNWN stock?

The intrinsic value of one KNWN stock under the Base Case scenario is 0.24 USD.

Is KNWN stock undervalued or overvalued?

Compared to the current market price of 1.52 USD, Know Labs Inc is Overvalued by 84%.